Your browser doesn't support javascript.
loading
Inotuzumab ozogamicin as single agent in pediatric patients with relapsed and refractory acute lymphoblastic leukemia: results from a phase II trial.
Pennesi, Edoardo; Michels, Naomi; Brivio, Erica; van der Velden, Vincent H J; Jiang, Yilin; Thano, Adriana; Ammerlaan, Anneke J C; Boer, Judith M; Beverloo, H Berna; Sleight, Barbara; Chen, Ying; Vormoor-Bürger, Britta; Rives, Susana; Bielorai, Bella; Rössig, Claudia; Petit, Arnaud; Rizzari, Carmelo; Engstler, Gernot; Starý, Jan; Bautista Sirvent, Francisco J; Chen-Santel, Christiane; Bruno, Benedicte; Bertrand, Yves; Rialland, Fanny; Plat, Geneviève; Reinhardt, Dirk; Vinti, Luciana; Von Stackelberg, Arend; Locatelli, Franco; Zwaan, Christian M.
Afiliación
  • Pennesi E; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.
  • Michels N; Department of Pediatric Oncology, Erasmus MC-Sophia Children's Hospital, Rotterdam, the Netherlands.
  • Brivio E; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.
  • van der Velden VHJ; Department of Pediatric Oncology, Erasmus MC-Sophia Children's Hospital, Rotterdam, the Netherlands.
  • Jiang Y; Oncode Institute, Utrecht, the Netherlands.
  • Thano A; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.
  • Ammerlaan AJC; Department of Pediatric Oncology, Erasmus MC-Sophia Children's Hospital, Rotterdam, the Netherlands.
  • Boer JM; Department of Immunology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, the Netherlands.
  • Beverloo HB; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.
  • Sleight B; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.
  • Chen Y; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.
  • Vormoor-Bürger B; Department of Pediatric Oncology, Erasmus MC-Sophia Children's Hospital, Rotterdam, the Netherlands.
  • Rives S; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.
  • Bielorai B; Oncode Institute, Utrecht, the Netherlands.
  • Rössig C; Department of Clinical Genetics, Erasmus MC, University Medical Center Rotterdam, Rotterdam, the Netherlands.
  • Petit A; Pfizer Inc, Groton, CT, USA.
  • Rizzari C; Pfizer Inc, Groton, CT, USA.
  • Engstler G; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.
  • Starý J; Pediatric Oncology and Hematology Department, Hospital Sant Joan de Déu de Barcelona, Barcelona, Spain.
  • Bautista Sirvent FJ; Institut de Recerca Sant Joan de Déu, Barcelona, Spain.
  • Chen-Santel C; Division of Pediatric Hematology and Oncology, Sheba Medical Center, Ramat-Gan, Israel.
  • Bruno B; Pediatric Hematology and Oncology, University Children's Hospital Muenster, Münster, Germany.
  • Bertrand Y; Department of pediatric Hematology and Oncology, Hopital Armand Trousseau, APHP, Sorbonne Université, Paris, France.
  • Rialland F; Pediatric Hematology-Oncology Unit, Department of Pediatrics, MBBM Foundation, ASST Monza, University of Milano-Bicocca, Monza, Italy.
  • Plat G; St Anna Children's Hospital, Medical University of Vienna, Vienna, Austria.
  • Reinhardt D; Department of Pediatric Hematology and Oncology, University Hospital Motol, Prague, Czech Republic.
  • Vinti L; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.
  • Von Stackelberg A; Department of Pediatric Oncology and Hematology, Hospital Niño Jesús, Madrid, Spain.
  • Locatelli F; Department of Pediatrics, Division of Oncology and Hematology, Charité - Universitätsmedizin Berlin, Berlin, Germany.
  • Zwaan CM; Department of Pediatrics, Rostock University Medical Centre, Rostock, Germany.
Leukemia ; 36(6): 1516-1524, 2022 06.
Article en En | MEDLINE | ID: mdl-35468945
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Asunto principal: Leucemia-Linfoma Linfoblástico de Células Precursoras / Calicheamicinas Límite: Adolescent / Child / Child, preschool / Humans / Infant Idioma: En Revista: Leukemia Asunto de la revista: HEMATOLOGIA / NEOPLASIAS Año: 2022 Tipo del documento: Article País de afiliación: Países Bajos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Asunto principal: Leucemia-Linfoma Linfoblástico de Células Precursoras / Calicheamicinas Límite: Adolescent / Child / Child, preschool / Humans / Infant Idioma: En Revista: Leukemia Asunto de la revista: HEMATOLOGIA / NEOPLASIAS Año: 2022 Tipo del documento: Article País de afiliación: Países Bajos